Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO).
Sign Up to like & getrecommendations! Published in 2021 at "Current vascular pharmacology"
DOI: 10.2174/1570161119666210118125424
Abstract: BACKGROUND Thromboangiitis obliterans (TAO) is a chronic, non-atherosclerotic, progressive inflammatory vascular disease affecting the small- and medium-size arteries and veins of the extremities. OBJECTIVE To evaluate whether long-term anticoagulation with low-molecular-weight heparin (LMWH) and warfarin… read more here.
Keywords: low molecular; obliterans tao; weight heparin; molecular weight ... See more keywords